Advertisement

Topics

Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind

07:18 EDT 10 Aug 2017 | Pharmafile

In possibly the biggest single biotech investment ever made, Swiss biotech firm Roivant has received a $1.1 billion cash injection thanks to an investment from Japanese telecom giant SoftBank.

At only three years old, Roivant is relatively new on the biotech scene, and operates via a range of its subsidiaries to pick up abandoned drugs from other companies’ pipelines and develops them to completion and commercialisation, either in the field for which it was originally intended or by reappropriating it for a new purpose.

read more

Original Article: Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind

NEXT ARTICLE

More From BioPortfolio on "Japanese telecom giant injects $1.1bn into Swiss biotech in largest-ever investment of its kind"

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...